A Phase II Study to examine the efficacy and safety of a new drug called Sevuparin on resolution of painful vaso-occlusive crisis in patients with sickle-cell disease.

drug protocol number
TVOC01
drug sponsor
Modus Therapeutics AB
drug study
Sevuparin
drug trial site
KKUH
drug status
Ongoing
drug phase